Who Exports Atenolol from India — 300 Suppliers Behind a $40.6M Market
India's atenolol export market is supplied by 300 active exporters who collectively shipped $40.6M across 3,681 shipments. IPCA LABORATORIES LIMITED leads with a 20.5% market share, followed by UNICHEM LABORATORIES LIMITED and AUROBINDO PHARMA LTD. The top 5 suppliers together control 60.2% of total export value, reflecting a concentrated market structure.
Top Atenolol Exporters from India — Ranked by Export Value
IPCA LABORATORIES LIMITED is the leading atenolol exporter from India, holding a 20.5% share of the $40.6M market across 3,681 shipments from 300 exporters. The top 5 suppliers — IPCA LABORATORIES LIMITED, UNICHEM LABORATORIES LIMITED, AUROBINDO PHARMA LTD, ZYDUS LIFESCIENCES LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED — collectively control 60.2% of total export value, indicating a moderately concentrated market. Individual shares are: IPCA LABORATORIES LIMITED (20.5%), UNICHEM LABORATORIES LIMITED (11.9%), AUROBINDO PHARMA LTD (10.0%), ZYDUS LIFESCIENCES LIMITED (9.4%), J B CHEMICALS AND PHARMACEUTICALS LIMITED (8.5%).
Top Atenolol Exporters from India
Ranked by export value · 300 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED ATENOLOL TABLETS BP 50MGATENOLOL TABLETS BP (11157X10XHARMLESS MEDICINES - ATENOLOL 50MG TABLETS | $8.3M | 18 | 20.5% |
| 2 | UNICHEM LABORATORIES LIMITED ATENOLOL 50MG 1000S USA EXPATENOLOL 50MG 1000'S USA EXP.ATENOLOL 50 MG & CHLORTHALIDONE 25 MG | $4.8M | 1 | 11.9% |
| 3 | AUROBINDO PHARMA LTD ATENOLOL TABLETS 100MG [9X10PER PACK]ATENOLOL 50MG 1000S USA EXPATENOLOL 50MG 1000'S USA EXP. | $4.1M | 3 | 10.0% |
| 4 | ZYDUS LIFESCIENCES LIMITED ATENOLOL TABLETS BP (11157X10XATENOLOL TABLETS 100MG [9X10PER PACK]ATENOLOL 50MG 1000S USA EXP | $3.8M | 13 | 9.4% |
| 5 | J B CHEMICALS AND PHARMACEUTICALS LIMITED ATENOLOL TABLETS 100MG [9X10PER PACK]ATENOLOL 50MG 1000S USA EXPATENOLOL 50MG 1000'S USA EXP. | $3.4M | 7 | 8.5% |
| 6 | LINCOLN PHARMACEUTICALS LTD ATENOLOL TABLETS BP (11157X10XATENOLOL TABLETS BP 50MG 10 X 10'SATENOLOL TABLETS BP ANOL-5042906X10X10 TAB | $1.5M | 5 | 3.7% |
| 7 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ATENOLOL TABLETS BP (11157X10XATENOLOL TABLETS BP 50MG (1ATENOLOL 25MG TABLETS 2X14'S | $1.4M | 5 | 3.5% |
| 8 | STRIDES PHARMA SCIENCE LIMITED ATENOLOL TABLETS 100MG [9X10PER PACK]ATENOLOL TABLETS 100MG [3X10PER PACK]ATENOLOL 50 MG AND NIFEDIPINE 20MG CAPSU | $1.3M | 2 | 3.1% |
| 9 | ADCOCK INGRAM LIMITED BIO ATENOLOL TABS 50 MG 3 X 10 SA EXPATENOLOL 50MG 2X14T SAF ARYA TEND-BLISTADCO-ATENOLOL 50MG TABLETS (ATENOLOL 50M | $953.7K | 1 | 2.3% |
| 10 | AUROBINDO PHARMA LIMITED ATENOLOL TABLETS 100MG [9X10PER PACK]ATENOLOL 50MG 1000S USA EXPATENOLOL 50MG 1000'S USA EXP. | $951.2K | 3 | 2.3% |
| 11 | AJANTA PHARMA LIMITED ATENOLOL TABLETS 100MG [9X10PER PACK]ATENOLOL TABLETS 100MG [3X10PER PACK]ATENOLOL 50 MG AND NIFEDIPINE 20MG CAPSU | $883.4K | 2 | 2.2% |
| 12 | J B CHEMICALS PHARMACEUTICALS LIMITED ATENOLOL TABLETS 100MG [9X10PER PACK]ATENOLOL 50MG 1000S USA EXPATENOLOL 50MG 1000'S USA EXP. | $834.6K | 2 | 2.1% |
| 13 | CADILA HEALTHCARE LTD ATENOLOL TABLETS BP (11157X10XATENOLOL 50MG 1000S USA EXPATENOLOL 50MG 1000'S USA EXP. | $613.8K | 3 | 1.5% |
| 14 | CIPLA LIMITED | $605.0K | 2 | 1.5% |
| 15 | KOPRAN LIMITED ATENOLOL 50 MG X 1000 COMP ( ATENOLBIO ATENOLOL TABS 50 MG 3 X 10 SA EXPATENOLOL 50MG 2X14T SAF ARYA TEND-BLIST | $553.2K | 5 | 1.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Atenolol exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | Approved | Yes | Yes | Multiple | Aurobindo Pharma Ltd holds FDA approvals, WHO-GMP certification, and EU GMP comp |
| Cipla Ltd | Approved | Yes | Yes | Multiple | Cipla Ltd maintains FDA approvals, WHO-GMP certification, and EU GMP compliance. |
| Ipca Laboratories Ltd | Approved | Yes | Yes | Multiple | Ipca Laboratories Ltd holds FDA approvals, WHO-GMP certification, and EU GMP com |
| Strides Pharma Science Ltd | Approved | Yes | Yes | Multiple | Strides Pharma Science Ltd maintains FDA approvals, WHO-GMP certification, and E |
| Zydus Lifesciences Ltd | Approved | Yes | Yes | Multiple | Zydus Lifesciences Ltd holds FDA approvals, WHO-GMP certification, and EU GMP co |
| Unichem Laboratories Ltd | Approved | Yes | Yes | Multiple | Unichem Laboratories Ltd maintains FDA approvals, WHO-GMP certification, and EU |
| J B Chemicals and Pharmaceuticals Ltd | Approved | Yes | Yes | Multiple | J B Chemicals and Pharmaceuticals Ltd holds FDA approvals, WHO-GMP certification |
| Ajanta Pharma Ltd | Approved | Yes | Yes | Multiple | Ajanta Pharma Ltd maintains FDA approvals, WHO-GMP certification, and EU GMP com |
| Cadila Healthcare Ltd | Approved | Yes | Yes | Multiple | Cadila Healthcare Ltd holds FDA approvals, WHO-GMP certification, and EU GMP com |
TransData Nexus reviewed the regulatory standing of 9 leading Atenolol exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Atenolol sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous API manufacturers, contributing significantly to India's pharmaceutical exports. Companies like Laurus Labs, headquartered in Hyderabad, focus on APIs and generic formulations, underscoring the city's prominence in bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its expertise in pharmaceutical formulations. This region is home to major companies like Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, which specializes in generic drugs and formulations. The presence of such companies highlights the region's strength in producing finished pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceuticals. Mumbai, being the financial capital, provides robust infrastructure and connectivity, facilitating the export of pharmaceutical products. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, leverage this strategic location to distribute their products globally.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. This region attracts numerous pharmaceutical companies, contributing to its status as a major production hub. The presence of such companies underscores the region's importance in the pharmaceutical manufacturing landscape.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical expertise and production capacities of suppliers, especially those specializing in APIs and formulations.
- Leverage Export Hubs: Utilize suppliers located in export-centric regions like Mumbai for efficient global distribution.
- Consider Tax Benefits: Explore partnerships with manufacturers in tax incentive zones to potentially reduce procurement costs.
By strategically sourcing from these diverse pharmaceutical clusters, companies can enhance supply chain resilience and optimize costs in the procurement of Atenolol.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Atenolol exporters from India
Zydus Lifesciences Limited — Zydus acquires Agenus' CDMO business
In June 2025, Zydus Lifesciences Limited acquired the contract development and manufacturing organization (CDMO) business of Agenus, including two biologics manufacturing sites in Emeryville and Berkeley. This acquisition aims to enhance Zydus' biologics manufacturing capabilities and expand its presence in the global pharmaceutical market. - IMPACT: The acquisition is expected to bolster Zydus' production capacity, potentially increasing Atenolol exports.
Impact: The acquisition is expected to bolster Zydus' production capacity, potentially increasing Atenolol exports.
Common Questions — Atenolol Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which atenolol supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, IPCA LABORATORIES LIMITED leads with 315 recorded shipments worth $8.3M. UNICHEM LABORATORIES LIMITED (266 shipments) and AUROBINDO PHARMA LTD (214 shipments) are also established high-volume exporters.
Q How many atenolol manufacturers are there in India?
India has 300 active atenolol exporters with a combined export market of $40.6M across 3,681 shipments to 124 countries. The top 5 suppliers hold 60.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for atenolol from India?
Average FOB unit price: $6.96 per unit, ranging from $0.00 to $2821.89. Average shipment value: $11.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 300 verified Indian exporters of Atenolol ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 3,681 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 124 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,681 Verified Shipments
300 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists